Growth Stimulation of Tumor-Specific Cytotoxic T Lymphocytes on Concanavalin A-Immobilized Carrier Beads

被引:0
|
作者
Shu Qin Liu
Lin-Shu Liu
Tadao Ohno
机构
[1] The Institute of Physical and Chemical Research (RIKEN),RIKEN Cell Bank
[2] Orquest,undefined
[3] Inc.,undefined
来源
Cytotechnology | 1998年 / 26卷
关键词
concanavalin A; cytotoxic T lymphocytes; immobilization; interleukin;
D O I
暂无
中图分类号
学科分类号
摘要
Human tumor-specific CD4+ cytotoxic T lymphocytes (CTL) were generated against duodenum papilloma cell line TGBC18TKB from HLA type-matched peripheral blood mononuclear cells. Concanavalin A (Con A) immobilized on carrier beads stimulated growth of the CTL in a long-term culture without repeated antigen stimulation, while soluble Con A induced death of the CTL. The CTL exhibited the target-specific cytotoxicity in a more potent manner than those before the long-term culture in the presence of the immobilized Con A. Enhanced expression of the adhesion molecule, CD11b, was observed on the CTL. These results suggest that immobilized Con A will be useful for continuous growth stimulation and large scale expansion of CTL without tumor antigen.
引用
收藏
页码:13 / 21
页数:8
相关论文
共 50 条
  • [41] EFFECT OF BETA-CAROTENE ON CYTOTOXIC ACTIVITY AND RECEPTOR EXPRESSION OF TUMOR-SPECIFIC LYMPHOCYTES
    AKPORIAYE, ET
    PETERSEN, A
    PIERCE, P
    VALENZUELA, J
    CANFIELD, L
    BENDER, J
    CAROTENOIDS IN HUMAN HEALTH, 1993, 691 : 264 - 266
  • [42] GENERATION OF TUMOR-SPECIFIC T-LYMPHOCYTES FOR THE TREATMENT OF POSTTRANSPLANT LYMPHOMA
    DIMAIO, JM
    VANTRIGT, P
    GAYNOR, JW
    DAVIS, RD
    COVENEY, E
    CLARY, BM
    LYERLY, HK
    CIRCULATION, 1995, 92 (09) : 202 - 205
  • [43] CONCOMITANT PRESENCE OF TUMOR-SPECIFIC CYTOTOXIC AND INHIBITOR LYMPHOCYTES IN PATIENTS WITH OSTEOGENIC-SARCOMA
    YU, A
    WATTS, H
    JAFFE, N
    PARKMAN, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (03): : 121 - 127
  • [44] Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor
    Baxevanis, CN
    Voutsas, IF
    Tsitsilonis, OE
    Gritzapis, AD
    Sotiriadou, R
    Papamichail, M
    JOURNAL OF IMMUNOLOGY, 2000, 164 (07): : 3902 - 3912
  • [45] Histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes from tumor-infiltrating lymphocytes of a patient with testicular embryonal cancer
    Suekane, S
    Nakao, M
    Inoue, M
    Noda, S
    Itoh, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (12): : 1181 - 1189
  • [46] Administrations of Tumor-Specific Cytotoxic T Lymphocytes Engineered to Resist TGF-β to Patients with EBV-Associated Lymphomas
    Bollard, Catherine M.
    Dotti, Gianpietro
    Gottschalk, Stephen
    Liu, Enli
    Sheehan, Andrea
    Mims, Martha
    Liu, Hao
    Gee, Adrian P.
    Brenner, Malcolm K.
    Heslop, Helen E.
    Rooney, Cliona M.
    BLOOD, 2010, 116 (21) : 248 - 248
  • [47] Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation
    Saitoh, S
    Kurisaka, M
    Mori, K
    Maeda, N
    Fujimoto, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (03): : 289 - 295
  • [48] Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96
    Janetzki, S
    Blachere, NE
    Srivastava, PK
    JOURNAL OF IMMUNOTHERAPY, 1998, 21 (04): : 269 - 276
  • [49] Trafficking of tumor peptide-specific cytotoxic T lymphocytes into the tumor microcirculation
    Ali, S
    Ahmad, M
    Lynam, J
    Rees, RC
    Brown, N
    INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (02) : 239 - 244
  • [50] Consequences of antigen self-presentation by tumor-specific cytotoxic T cells
    Staege, MS
    Schneider, J
    Eulitz, M
    Scholz, S
    Bornkamm, GW
    Wölfel, T
    Reske-Kunz, AB
    IMMUNOBIOLOGY, 2000, 201 (3-4) : 332 - 346